首页> 外文期刊>Journal of Radiation Research: Official Organ of the Japan Radiation Research Society >Hemithoracic intensity-modulated radiotherapy using helical tomotherapy for patients after extrapleural pneumonectomy for malignant pleural mesothelioma
【24h】

Hemithoracic intensity-modulated radiotherapy using helical tomotherapy for patients after extrapleural pneumonectomy for malignant pleural mesothelioma

机译:恶性胸膜间皮瘤胸膜肺切除术后半螺旋体强度调节放疗

获取原文
获取原文并翻译 | 示例
           

摘要

Postoperative hemithoracic irradiation is regarded as an important part of the curative treatment for resectable malignant pleural mesothelioma (MPM). Because the clinical target volume in postoperative MPM is irregular and surrounded by dose-limiting critical structures, intensity-modulated radiation therapy (IMRT) is thought to be suitable. However, postoperative hemithoracic IMRT remains experimental due to a high incidence of fatal pneumonitis. Therefore, a Phase I dose escalation study for hemithoracic IMRT using helical tomotherapy was planned, and the results of the first three patients are herein reported because this technique may provide benefits to such patients. For 3 patients with postoperative MPM, who were treated by extrapleural pneumonectomy (EPP), a radiation dose of 45.0 Gy in 25 fractions was given to cover 95% of the PTV. The lung V5s of the three patients were 14.3%, 10.0%, and 31.3%, respectively. The V5s of the present plans was smaller than that of the recent IMRT planning studies. The lung V20s of these patients were 2.4%, 2.2%, and 4.3%, respectively. Their MLDs were 4.3 Gy, 3.4 Gy, and 5.8 Gy, respectively. The follow-up periods of the patients were 26, 14 and 9 months from initiation of IMRT, respectively. All patients were alive, although local and contralateral recurrences had developed in 1 patient. Only 1 patient had Grade 2 acute esophagitis and nausea. There was no treatment-related pneumonitis. Hemithoracic IMRT using helical tomotherapy may play a crucial role in adjuvant treatment for MPM after EPP.
机译:术后半胸腔放疗被认为是可切除恶性胸膜间皮瘤(MPM)的重要治疗方法。由于术后MPM的临床目标体积是不规则的,并且被限制剂量的关键结构所包围,因此,认为强度调节放射治疗(IMRT)是合适的。然而,由于致命性肺炎的高发率,术后半胸腔IMRT仍处于实验阶段。因此,已计划使用螺旋层析疗法进行半胸腔IMRT的I期剂量递增研究,并且在此报告前三名患者的结果,因为该技术可能为此类患者带来益处。对于3例经胸膜外肺切除术(EPP)治疗的MPM术后患者,给予25个剂量的45.0 Gy放射剂量以覆盖95%的PTV。三名患者的肺V5分别为14.3%,10.0%和31.3%。当前计划的V5小于最近的IMRT计划研究的V5。这些患者的肺V20分别为2.4%,2.2%和4.3%。它们的MLD分别为4.3 Gy,3.4 Gy和5.8 Gy。从IMRT开始,患者的随访期分别为26、14和9个月。所有患者都还活着,尽管有1位患者发生了局部和对侧复发。仅1例患有2级急性食管炎和恶心。没有与治疗有关的肺炎。使用螺旋体层摄影术的半胸腔调强放疗可能在EPP后MPM的辅助治疗中起关键作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号